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Abstract  
Pathogenic foodborne bacteria, particularly species belonging to Listeria and 
Salmonella, pose a growing threat to public health because of their ability to form 
and/or grow within biofilms on various environments, specifically food processing 
facility. Within a biofilm, bacteria develop increased resistance to common 
disinfectants, making surface sterilization a challenge for businesses involved in food 
processing. In order to determine the viability of bacteriophages as an antibiotic 
alternative, this experiment attempted to explore the bacteriophage growth process as 
well as bacteriophage efficacy against Listeria monocyogenes as compared to 
Salmonella enterica serovar Typhimurium. A511 bacteriophage was grown and tested 
on L. monocytogenes 1/2a using previously studied P22 bacteriophage and S. enterica 
as a control case. While this experiment was unable to establish a defined efficacy of 
A511 against L. monocytogenes, repeatable results with Salmonella show promising 





















Thesis submitted in partial fulfillment of the requirements of the Gemstone Program 




Dr. Debabrata Biswas, Mentor 
Dr. Daniel C. Nelson, Discussant 
Dr. Mengfei Peng, Discussant 
Dr. Serajus Salaheen, Discussant 
















© Copyright by 
 
Team PHAGE 
Sarah Frail, Gina Liu, Grace Macatee, Tejas Mavanur, Kerina Ochieng, Cara Purdy, 









The team would like to acknowledge the following people for their extensive 
contributions to our project and assisting our team with our writings, posters and 
presentations, experiments, funding, and the many other challenges that have arisen 
during the process. 
❖ Dr. Debabrata Biswas - Team Mentor 
❖ Nedelina Tchangalova - Team Librarian 
❖ The Gemstone Program and associated section leaders and staff 
❖ Dr. Frank J. Coale - Gemstone Program Director  
❖ Dr. Kristan Skendall - Gemstone Program Assistant Director 
❖ Vickie Hill - Gemstone Program Assistant Director for Operations 
❖ Graduate students and Postdocs of the Biswas Lab 
➢ Dr. Mengfei Peng 
➢ Zajeba Tabashsum 
➢ Dr. Serajus Salaheen  
➢ Dr. Vinod Nagarajan 
➢ Dr. Juhee Ahn 
❖ Former and visiting members of the team 
➢ Liam Peabody 
➢ Amber Brauer  
❖ Thesis defense committee members 
➢ Dr. Daniel C. Nelson 
➢ Dr. Serajus Salaheen 




➢ Dr. Mengfei Peng 
❖ The Launch UMD Campaign platform and the many generous donors who 




Table of Contents 
 
INTRODUCTION 4 
Biofilm formation 4 
Bacteriophage Structure and Replication 6 
Targeted Environments for Phage Therapy 111 
Applications of Phages 133 
Bacteriophage Delivery Methods 144 
Product Examples 155 
METHODOLOGY 200 
1. Growth of Bacterial Stock 200 
1.1 Strains and Culture Conditions .................................................................... 200 
1.2 L. monocytogenes 1/2a Standard Curve for Average CFU ......................... 200 
2. Growth of Phage Stock and Modifications 211 
2.1 Bacteriophage A511 Propagation ................................................................ 211 
2.2 Modifications to A511 Growth Method ...................................................... 211 
3.  Plaque Assay and Modifications 233 
3.1 Semi-Soft Agar Phage Titer Plaque Assay .................................................. 233 
3.2 Modifications to Semi-Soft Agar Plaque Assay .......................................... 233 
3.3 Bacterial ‘Lawn’ Plaque Assay .................................................................... 255 
4. Salmonella Growth, Phage Stock, and Biofilm Assay 255 
4.1 Growth of P22 Phage ................................................................................... 255 
4.2 Biofilm Attachment Ability Assay .............................................................. 266 
4.3 Enumeration of attached cells ...................................................................... 266 
RESULTS 277 
L. monocytogenes Standard Curve 277 
Low L. monocytogenes Concentration Tests 27 




L. monocytogenes Lawn Plaque Assay Initial Results 30 
L. monocytogenes vs. S. enterica serovar Typhimurium: 355 
DISCUSSION 377 
Current Research 433 
Future Directions 466 
Appendix: Glossary 48 






List of Figures 
Figure  Page 
1 Biofilm Formation Phases. 4 
2 Morphology of Phage T4. 7 
3 Life Cycle of the Typical 
Phage. 
9 
4 L. monocytogenes 
Standard Curve. 
27 
5 Ascertaining Phage Stock 
Titer. 
28 
6 Variability of Semi-soft 
Agar. 
29 
7 Lawn Plaque Assay. 30 
8 Lawn Plaque Assay at 
Room Temperature. 
31 
9 Gram-stain of L. 
monocytogenes. 
32 
10 Lawn Plaque Assay Using 
New ATCC A511. 
33 
11 Lawn Plaque Assay Using 
Undiluted ATCC A511. 
34 
12 Parallel Lawn Plaque 
Assays of A511 and P22. 
35 
13 Plaque Formation with 





   
List of Tables 
Table  Page 
1 Common Biofilm 
Forming Bacteria, 







Increasing rates of bacterial infection by antibiotic resistant bacteria 
are a growing threat to public health. In 2013, the U.S. Center for Disease 
Control and Prevention (CDC) reported that two million people were infected 
by antibiotic-resistant bacteria and 23,000 people died from their infection in 
the U.S. alone (CDC, 2013). Overuse of antibiotics, particularly in the meat 
and dairy industry, is thought to cause many pathological bacterial species to 
develop resistance to multiple classes of antibiotics. (Landers, Cohen, Wittum 
& Larson, 2012) In the US, 80% of all antibiotics sold are administered in 
animal agriculture, 70% of which are relevant to human health (Martin, 
Thottathil, & Newman, 2015).  
  The adverse effects of bacteria not only impact medicine, but also 
agriculture, where strains of Escherichia coli, methicillin-resistant 
Staphylococcus aureus (MRSA), and Listeria monocytogenes affect both 
animals and humans, resulting in billion-dollar losses (Schroeder, 2012).  
Outbreaks of infection have amplified public concern.  Cases of listeriosis 
caused by ice cream products contaminated with L. monocytogenes forced 
massive product recalls by Blue Bell Creameries in 2015 (U.S. Food and Drug 
Administration [FDA], 2015).  From 2010 to 2016, there were 39 foodborne 
outbreaks of L. monocytogenes, resulting in 379 hospitalizations and 84 deaths 
in the U.S alone (CDC, 2018). Mortality rates are especially high in 
immunocompromised individuals, the elderly, children, and pregnant women 
(Colagiorgi, Di Ciccio, Zanardi, Ghidini, & Ianieri, 2016). As highlighted by 
U.S President Barack Obama in the Executive Order No. 13,676 (2014), 




for public health and the global economy warrant a larger allocation of the 
federal budget towards research for antibiotic alternatives. 
 A promising solution to controlling antibacterial resistance is the 
implementation of phage therapy, which involves the use of bacteriophages to 
kill specific bacteria with minimal adverse effects. The inception of phage 
therapy is noted by Maura & Debarbieux (2011), who explain that the 
discovery of bacteriophages in 1915 by Frederick W. Twort quickly gave rise 
to various forms of phage therapy which became prevalent in the 1920s and 
1930s.  However, the development of antibiotics in the 1940s diminished 
consumer use of the phages.  Phages then became models of experimentation 
that furthered the field of molecular biology (Maura & Debarbieux, 2011).  
Bacteriophage therapy became popularized as an alternative to 
antibiotics in countries such as the former Soviet Union and England and is 
still being used successfully today (Kutter et al., 2010).  The high regulatory 
hurdles of medical application mean that with only more higher-level clinical 
trials will phage therapy be accepted in the U.S. medical community 
(Matsuzaki et al., 2003). 
Phage therapy has seen rapid advancement in the food industry, where 
applications towards pathogen prevention and treatment have been extensively 
researched (Maura & Debarbieux, 2011).  These food safety measures include 
the inhibition of bacterial colonization in domesticated livestock, disinfection 
of inanimate surfaces, and post-harvest administration to food surfaces 
(Sulakvelidze, 2013). Products such as Listex™, ListShield™, Ecophage™, 
and Agriphage™ have manifested from this research.  However, a lacking area 




L. monocytogenes prevalence in the food industry is attributed to its 
ability to form biofilms on surfaces in cold temperatures via production of 
extracellular polymeric substances (EPS) (Di Bonaventura et al., 2008; 
Blackman & Frank, 1996). The EPS is comprised of sugars, proteins, and 
DNA that function in aggregation, adhesion, and protection of the inner 
bacteria (Flemming & Wingender, 2010). Antibiotics are less effective at 
killing L. monocytogenes in biofilms than when bacteria are free-floating, 
primarily due to the EPS physically blocking antibiotic treatment from coming 
into contact with cells, as well as the formation of dormant persister cells 
within the biofilm colony (Carpentier & Cerf, 2011; Wu, Yu, & Flint, 2017).  
In other studies, bacteriophages were also found to infect the metabolically 
inactive persister cells and secrete polysaccharide depolymerases (e.g. alginate 
lyases, hyaluronidases) that disrupt the biofilm matrix (Harper et al., 2014). 
However, the specific depolymerases and other enzymes responsible for EPS 
disruption in L. monocytogenes phage have yet to be identified. Research 
pertaining to biofilms may broaden the range of biosanitation uses for phages 
and further the field of antibiotic alternatives.  
A number of bacteriophages have been isolated and proven to reduce 
bacterial populations of L. monocytogenes (Lee, 2017).  A study from 2009 
showed that a lytic strain of bacteriophage called A511 can infect 95% of all 
strains of L. monocytogenes (Guenther, Huwyler, Richard, & Loessner, 2009). 
Additionally, several examples of disinfectants composed of phage have been 
marketed and produced successfully. These products combine multiple phages 
into a cocktail to broaden the disinfecting scope (Sulakvelidze, 2013). In the 




bacteriophages led to greater reduction of Salmonella enterica colonies at 4°C 
(the typical temperature of factories and processing facilities) than at 18°C 
(Galarce, Bravo, Robeson, & Borie, 2014).   
 
Biofilm formation  
Biofilm formation can be summarized in three basic stages: initial 
attachment, maturation, and dispersion (Monroe, 2007; O'Toole, Kaplan, & 
Kolter, 2000). These phases are illustrated in Diagram 1 and then described 
below.  
 
Figure 1: Biofilm Formation Phases. An illustration of the attachment and 
maturation phases of biofilm formation. Diagram is based on information 
obtained from Monroe (2007) and adapted from a figure from Harper et al., 
(2014). 
 
Attachment Phases: Initial attachment involves the use of van der 
Waals and hydrophobic interactions between the cell and the attachment 
surface, aided by cell appendages such as pili, represented as thin external 
hairs in Figure 1. As surface roughness increases, colonization by bacteria 




2002). There have been experiments conducted testing the biofilm-forming 
ability of bacteria on smooth surfaces, unfortunately achieving this is difficult 
because only a few bacteria need to adhere in order for a successful biofilm to 
form and grow (Monroe, 2007). Once adhered, cells alter their gene 
expression to allow them to survive in the oxygen depleted environment of the 
biofilm, upregulating genes that will favor fermentation over aerobic 
respiration (Donlan, 2002). 
Maturation Phases: As the biofilm grows, the bacteria will produce 
the EPS, which consist of an array of materials such as carbohydrates, 
polypeptides, metals, DNA and lipids in varying relative amounts dependent 
on the environment and native bacteria of the biofilm. Overall, carbohydrates 
are the most abundant, and typically DNA and lipids are present in only more 
trace amounts. As a biofilm matures, both the mass of EPS and the ratio of 
EPS to bacteria increase, suggesting that EPS production occurs at a faster rate 
relative to bacterial replication (Jiao et al., 2010). Once fully grown, EPS can 
make up 50%-90% of biofilm mass. EPS is also amphipathic and extremely 
insoluble, making it even more difficult to remove or penetrate with 
disinfectants. Additionally, while bacteria are isolated and growing inside a 
biofilm, they are in an ideal environment to exchange plasmids containing 
DNA that could confer resistance to certain antibiotics, increasing the portion 
of a bacterial population that is resistant. The later phases of maturation are 
also when persister cells begin to develop, as bacteria enter a dormant state in 
which they resist uptake of antibiotics (Donlan, 2002). 
Dispersion: The dispersion stage (not illustrated in Figure 1) of 




occur when bacteria in the biofilm break away, often due to nutrient changes 
in the environment. Since the biofilm is able to survive and re-adhere when 
pieces are broken off, incomplete attempts to remove it or any other stress on 
the surface can aid in its dispersal (Donlan, 2002). Bacteria in their dispersal 
phase have gene expression distinct from both bacteria in biofilms and free-
floating bacteria. This altered gene expression may aid in a cell’s ability to 
break away from the host biofilm and has been found to increase their 
virulence against macrophages (Chua et al., 2014). 
 
Bacteriophage Structure and Replication 
Bacteriophage are typically comprised of a nucleic acid - such as 
double-stranded DNA - and proteins that interact together to form the 
characteristic complex structure of the bacteriophage (Cann, 2001). The vast 






Figure 2: Morphology of Phage T4. T4 is part of the Myoviradae family of 
viruses, characterized by their lack of a lipid bilayer enveloping the protein 
capsid of the head. Figure adapted from Kostyuchenko et al., (2003).  
 
Bacteriophages are highly specific to the strain of bacteria which they 
infect and are therefore generally non-toxic to humans or the normal bacterial 
gut environment of humans. Studies have shown that bacteriophages can be 
incredibly specific, such that that a strain which infects E. coli cells in vitro 
will not infect wild-type E. coli in the gut of mouse or even human test 
subjects. Additionally, many types of bacteriophage already inhabit the gut, 
and do no harm their host organism. (Bruttin & Brüssow, 2005; Chibani-
Chennoufi et al., 2004). 
When bacteriophages like A511 ATCC PTA-4608 detect and bind to 




conformational change that results in retraction of the base plate and tail. This 
retraction causes the sheath to pierce the membrane of the bacterial cell, 
creating a pathway through which the nucleic acid (dsDNA in the case of 
A511) can be inserted, traveling from the capsid head, through the sheath and 
into the bacterial cytosol (Orlova, 2009).  
Once the bacteriophage nucleic acid is inserted into the cell, the cell 
can enter the lysogenic (integrative) or lytic (replicative) phases, as shown in 
Figure 3.  In the lysogenic phase, the previously inserted bacteriophage DNA 
becomes a part of the bacterial genome.  The integration of DNA into the 
bacterial chromosome suppresses phage reproduction.  Primarily lysogenic 
phages contain host-controlled modification systems and restriction systems 
that have a negative effect on the quality and quantity of DNA translated into 
the bacterium.  Studies conducted testing the lysogenic qualities of phages by 
using Bacillus subtilis show that the bacteriophages were successful in 
bacterial transduction*; however, the bacteria were unable to maintain high 
levels of transfection*.  The study concluded that although bacteriophages 
have the capability to parasitize a host, the lysogenic phages either integrate 
their DNA into the host’s genetic material or remain in the plasmid for an 
extended period of time (Yasbin, Wilson, & Young, 1973).  Although this may 
be useful in certain situations, the paused reproduction state, also known as the 
temperate phase, renders this cycle less useful for application for disinfection.  
However, it is possible for lysogenic phages to revert back to the lytic phase 
through the removal of nucleic acid from the bacteria’s chromosome or the 




For disinfectant-related applications, the lytic phase is more desired 
due to its ability to lyse bacteria.  During this reproductive phase, 
bacteriophage parts accumulate in the host cell’s cytoplasm and eventually 
form into complete progeny phage. To release these progeny phage from the 
cytoplasm, enzymes called lysins must deteriorate peptidoglycan* in the cell 
wall of the bacterial host.  The phage lysins require an additional protein, 
holin, to guide lysins through the bacterial membrane.  Holin is a small 
membrane protein that provides the lysins with access to the cell wall, 
allowing the lysins to disrupt peptidoglycan bonds. These enzymes create 
large patches in the cell wall, which cause the bacteria to burst and release the 
phages into the environment (Fischetti, 2008; Wang, Smith, & Young, 2000; 
van Heijenoort, 2001).  
 
 
Figure 3: Life Cycle of the Typical Phage. A bacteriophage will attach to 




left behind.  From there, phages can enter the lytic or lysogenic phase to 
continue their life cycle.  Diagram adapted from Campbell, A. (2003).  The 
future of bacteriophage biology.  Nature Reviews Genetics, 4(6), 471-477.   
 
Bacteriophages possess a high specificity to the bacteria they infect, 
with their proteins acting similarly to that of the lock-and-key with bacterial 
surface proteins.  When in an environment with no complementary bacteria, 
bacteriophages are inactive.  However, in the presence of compatible bacteria, 
the phage’s proteins automatically bind to the bacteria.  In prior studies phages 
have significantly reduced or completely eliminated Listeria on the surface of 
cheese and had no negative effects when orally given to mice.  Further 
mixtures with varying concentrations of phages resulted in varying degrees of 
effectiveness (Carlton, Noordman, Biswas, de Meester, & Loessner, 2005).  In 
the case of E. coli, the phage used was applied in various environments with 
differing conditions.  For example, the phage was applied in cool or warm 
locations, in varying concentrations, and with different contact times (Hudson 
et al., 2013).   
The use of bacteriophages in environments with varying temperatures 
may result in different results as well.  A 2004 study showed that the greatest 
reduction of Salmonella on salmon was found in the cooler condition of 4 
degrees Celsius, rather than at a warmer 18 degrees Celsius (Galarce, Bravo, 
Robeson, & Borie, 2014).  Moreover, two phages were tested on Salmonella 
and Campylobacter grown on both roast and raw beef. Bacteriophages and 
their hosts were set in conditions with varying temperature, times, amounts of 




Smith, & Heinemann, 2008).  The study suggests the greatest eradication 
occurred when the bacterial density was high and with contact time of 24 
hours.  For Campylobacter bacteria, the largest reductions in cell colonies 
were found in the case of a high host cell density on both raw and cooked 
beef.  In both cases, inactivation of the pathogenic bacteria occurred as time 
increased.  Reflection upon previously published literature leads to questions 
of what specific concoction of phages, as well as what conditions and settings, 
will maximize elimination of the most bacteria (Bigwood et al., 2008).   
 
Targeted Environments for Phage Therapy 
Foodborne diseases cost the U.S. over 5 billion dollars in medical costs 
and lost production per year (Fey, Mills, Coffey, Mcauliffe, & Ross, 2009).  
The potential lost profit is a large motivator for companies to take action 
against bacterial infection, and due to the increase of bacterial resistance, there 
is also pressure to search for alternatives to antibiotics.  In addition to high 
costs and lost profits, foodborne illnesses pose a huge risk to public health.  
Over 2,000 hospitalizations and 500 deaths are caused per year by listeriosis, 
the disease caused by Listeria monocytogenes which is a common foodborne 
bacterial pathogen present in food processing (Fey et al., 2009).  
Bacteriophage A511 have previously been shown to have significant potential 
for addressing breakouts of L. monocytogenes (Guenther, Huwyler, Richard, 
& Loessner, 2009).  Other types of bacteria such as Salmonella occur in an 
immense range of food products including leafy greens, tomatoes, and poultry 




human health are a prevailing issue will be listed in Table 1 and then 
examined in greater detail below.   
Table 1: Common Biofilm Forming Bacteria, Symptoms, and Sources# 
 
#A summary of the various different types of bacteria that are capable of 
forming or growing within biofilms, the symptoms infections by these bacteria 
can cause, and the common sources. Table information obtained from 
Endersen, O’Mahony, Hill, Ross, McAuliffe, & Coffey (2014).    
 
Meat packing industry.  The meat packing industry is highly 
susceptible to foodborne illnesses.  Certain types of bacteria can emit an EPS.  
The EPS allows bacteria to adhere to each other and therefore collect on 
various surfaces in the form of biofilm, providing protection from certain 
environmental factors (Vert et al., 2012).  One of the dangers of biofilms is 




of free-floating bacteria; the protected environment of the film increases their 
resistance to common detergents and antibiotics.  
Another important factor to consider is the colder temperature at which 
meat packing plants operate in order to preserve their products.  Phage testing 
on cheeses have investigated the effects of temperature on phage disinfectants.  
Bacteriophage P100, which targets Listeria, was shown to be severely 
weakened under refrigeration compared to 10 degrees Celsius (Silva, 
Figueiredo, Miranda, & Almeida, 2013).  
Hospitals.  Hospitals suffer from medical instrument and surface 
contamination from bacterial biofilms. Biofilm contamination of polymeric 
substances, such as intravenous tubing and catheters, often go unnoticed and 
may lead to infection of the patient.  Many potentially infections bacteria - 
including MRSA, vancomycin resistant enterococcus, and Pseudomonas 
species - were the most commonly found biofilm creating species (Vickery et 
al., 2014).  Bacteriophages, however, are able to break down biofilms and 
infect the bacteria inside (Harper et al., 2014).  Subsequent phage treatment to 
equipment also significantly reduced biofilm regrowth (Ryan, Gorman, 
Donnelly, & Gilmore, 2011).  
Applications of Phages         
Bacteriophages are a potential solution to the recent consumer demand 
for natural and safe antimicrobials as opposed to chemical preservatives in the 
agro-food industry.  Use of certain phages in animal and plant food 
production, processing, and handling can prevent the spread of bacterial 
diseases and ultimately promote a safer environment.  Phages can be utilized 




biosanitation, and biopreservation.  Phage therapy in animals before slaughter 
or during animal growth could help reduce pathogens and possible cross-
contamination with feces.  Another agro-food application for phages would be 
biocontrol, which is applying phages directly on the surface of food such as 
milk, meats, or fresh produce (Sillankorva, Oliveira, & Azeredo, 2012).  
Phages are reported to lyse hosts at temperatures as low as 1°C, so they could 
also be used as a food biopreservation agent to prevent growth of bacteria on 
refrigerated foods (Greer, 1988).  Once the food is returned to room 
temperature, the phages are more effective in limiting bacterial growth 
(Bigwood et al., 2008). The most feasible application for this investigation 
was determined to be biosanitation of the biofilm that forms on the surface of 
equipment used in the food industry.    
 
Bacteriophage Delivery Methods 
Aerosol.  Research by Keyang et al. (2012) suggested that in order to 
disperse phages so that incidence with bacteria is increased, an aerosol 
distribution method is an option.  The team explored which conditions best 
offer tuberculosis-specific phage D29 ideal generation within an aerosolized 
phage solution.  Using a nebulizer and a closed chamber the efficacy of 
multiple spray liquids, sampling medium, storage temperature, different 
humidities, as well as the best method of sampling were all studied.  The 
group determined, using the solution with the highest resultant concentration 
of culturable phages, that the aerosol solution functions best in a relatively low 
(<25%) humidity.  Use of deionized water offered vastly more culturable D29 




temperature, both used sample media (SM buffer and nutrient broth) offered 
near identical results, and of the two sampling methods, a biosampler and the 
AGI-30, neither performed significantly better than the other (Keyang et al., 
2012).  Aerosolization of phages opens a wide field of applications, but still 
has yet to see marketable usage. 
Spray.  Leverentz, Conway, and Janisiewicz (2004) investigated the 
effectiveness of phages at combatting honeydew melons that were inoculated* 
with L. monocytogenes.  Their approach included introducing the phages to 
the melon via a spray applicator, to increase the dispersion of phages along the 
fruit surface.  The group studied how the timing of application of the phages 
affected the resulting culture of bacteria, as well as the concentration of phage 
applied.  They found that for best results (undetectable bacterial population 
after 7 days) a concentration of 108plaque forming units/mL (PFU/mL) 
applied less than one hour after inoculation is necessary (Leverentz et al., 
2004).  The fact that the phage solution is applicable and still effective against 
listeria when sprayed on a fruit surface opens a wide field for all phage 
products to work within. There are a handful of existing products similar in 
nature to the scope of this research. 
 
Product Examples 
 Several examples of phage disinfectants have been marketed and 
produced successfully. These products show that a phage disinfectant is 
possible to use against many strains of bacteria. However, these products fail 




L. monocytogenes and combine them in some way with current antibiotics or 
disinfectants to rescue* them. 
ListexTM.  The FDA-approved Listex P100TM contains a single lytic 
phage P100 and can be used to reduce biofilm matrices caused by L. 
monocytogenes in food processing environments.  It was found that P100 is 
active against a wide range of L. monocytogenes in biofilm conditions as it 
significantly reduced cell populations when applied to stainless steel surfaces 
for a 24 hour period.  However, different strains of L. monocytogenes had 
statistically different optical densities when comparing the control and phage 
treatment results.  A cocktail* with mixtures of different phages might provide 
a more effective real-world disinfectant because in an uncontrolled, real-world 
setting different strains of bacteria and the possibility of phage resistance 
could cause issues (Soni and Nannapaneni, 2010).  Also, the ratio of 
bacteriophages to host cells is important as it is shown that higher 
concentrations of bacteriophages, also known as multiplicity of infection 
(MOI), are more effective at controlling L. monocytogenes.  The most 
effective concentration of P100 found was 7-log PFU/ml (MOI of 5.13) 
because it produced the greatest phage reductions in the least amount of time 
(Montañez-Izquierdo, Salas-Vázquez, Rodríguez-Jerez, 2011).  The age of the 
biofilm is also important, as a one week old biofilm was measured as having a 
phage reduction of 2-log colony forming units/cm2 (CFU/cm2) less than a 2 
day old biofilm (Soni & Nannapaneni, 2010). 
ListShieldTM.  ListShieldTM is a phage cocktail* that contains more 
than 6 different types of lytic phages and has shown to be effective against 170 




concentrated, aqueous, phage preparation that is stored at 2-6°C and then 
diluted with clean water when ready for use (Intralytix, n.d.).  It is 
Environmental Protection Agency (EPA)-approved for use on surfaces in food 
facilities and is FDA-approved for meat, poultry, and fish products as a 
surface treatment (Nannapaneni & Soni, 2015).  However, it is mandated by 
the FDA that ListShieldTM cannot be used as a ‘stand-alone’ protocol but as 
part of the overall sanitization of a surface.  Also, it is necessary to wait five 
minutes after application before using any other chemical product to ensure 
that the chemical sanitizers do not inactivate the phages (Sulakvelidze, 2013).   
EcoShieldTM.  EcoShieldTM is a marketed bacteriophage cocktail* 
composed of three E. coli specific strains (Carter et al., 2012).  Researchers 
tested the safety of the product, the significance of E. coli reduction in lettuce 
and beef under usual storage conditions and protect against recontamination.  
When EcoShieldTM tested on artificially contaminated beef steaks, E. coli cells 
were infected by phages within the first 5 minutes and protection against the 
initial bacterial load was maintained over a period of 7 days of refrigeration.  
However, there was no significant protection against the recontamination with 
E. coli. Subsequent treatment of the meat with EcoShieldTM yielded no 
bacterial resistance to the phage cocktail*.  EcoShieldTM’s dependency on 
concentration or dilution was examined through contaminated lettuce leaves, 
which had EcoShieldTM applied to them and then the leaves were treated with 
water to dilute the phages present.  Although the moisture slightly reduced 
efficacy of the treatment, the dilution initially decreased bacterial load.  
Chemical analysis found that there were very low levels of non-phage 




would be negligible, and thus potentially viable for an aftermarket 
decontaminant (Carter et al., 2012).  
AgriphageTM. AgriphageTM is an experimentally licensed phage 
cocktail* product that is aimed at combatting bacterial disease among 
commercially grown plants.  Its efficacy in doing so was studied by Obradovic 
et al. (2005) in connection with other products with similar goals although 
different methods.  Functioning alone, Agriphage™ did nothing to slow or 
reduce bacterial infection of tomato leaves studied, however when used in 
conjunction with other antibacterials, it provided the best method of 
combatting infection (Obradovic et al., 2005).  A different multiyear study was 
also conducted where sprays of AgriphageTM on greenhouse tomato plants 
were investigated for their efficacy in combating bacterial cankers.  
AgriphageTM was not only effective in combating and reducing the canker, it 
also outperformed other standard methods in doing so (Ingram & Lu, 2009).  
This is interesting to note as it is a potentially viable area for phages to fit in 
within the larger context of antibacterials in the agriculture industry. 
As bacterial antibiotic-resistance continues to grow, research has shown that 
bacteriophages are an effective alternative to the classical wide-spectrum 
antibiotic. Bacteriophages may be manipulated to account for bacterial 
resistance.  As such, the concern for bacterial resistance development, in 
comparison to antibiotics, is of a lower degree.  With gene sequencing, it is 
possible to observe and extinguish resistance on the genetic level, whereas 
with antibiotics, it is nearly impossible to make such minute changes.  
Through the use of a phage cocktail*, it is possible to target most of the major, 




ecosystem of other bacteria in the area.  Furthermore, phages are effective 
against biofilms, while most classical cleaning methods fail to penetrate the 
biofilm.  Bacteriophages, however, have the ability to not only infiltrate the 
biofilm but also lyse the bacteria within (Harper et al., 2014).  A growing issue 
in the meatpacking industry, as well as related fields, is the biofilm-forming 
bacteria, but a phage cocktail* will be an effective countermeasure.  A 
potential issue with the use of bacteriophages is if the virus enters the 
lysogenic cycle upon entering a bacterium, as opposed to the lytic cycle.  In 
the first case, the incorporation of virus DNA into bacterial DNA could create 
a wholly new strain of pathogenic DNA and as such it is imperative that the 
phage cocktail* always results in 100% lytic phage.  Through deliberate 
experimentation, such a product can be achieved, which will have significant 
implications for bacterial sanitation in the food production industry and 
















1. Growth of Bacterial Stock 
1.1 Strains and Culture Conditions  
Frozen stocks of L. monocytogenes strain 1/2a originally purchased 
from American Type Culture Collection (ATCC BAA679), Manassas, VA, 
USA were cultured in Brain Heart Infusion (BHI) broth and maintained over 
time by culturing on BHI agar plates and periodically sampling single colonies 
for re-culturing on plates or in broth. Culture plates were stored in the 4°C 
before use. Stock cultures of Salmonella enterica serovar Typhimurium 
originally purchased from ATCC (ATCC14028) were maintained by the same 
method but in Trypticase Soy Broth (TSB) or Luria Broth (LB). Broths were 
prepared by adding the labeled weight amounts of powdered broth to 
corresponding amount of distilled water, sterilizing in an autoclave for 20 
minutes, and storing at 4°C for up to two weeks. Plates were prepared 
similarly but by adding 1.5% bacto agar. 
 
1.2 L. monocytogenes 1/2a Standard Curve for Average CFU 
A single L. monocytogenes colony was lifted from an agar plate and 
swished in warmed BHI media in a 15 mL tube. The tube was shaken at 37°C 
for 24 hours, centrifuged for 8 min at 3000g, and resuspended in new media to 
an OD of 0.1 with an absorbance wavelength of 600 nm. The 0.1 OD solution 
of bacteria was serially diluted down to 10-7 of the original. Aliquots of 25μL 
of each dilution starting at 10-2 OD down to 10-7 OD were spread in triplicate 
onto a plate using a flattened pipette. Plates were incubated at 37°C for 24 




count values were averaged, and CFU/mL values were plotted against Log 
(OD). Bacterial solutions with OD’s as high as 0.5 and as low as 10-9 were 
also plated but resulted in colony over and under growth respectively. 
 
2. Growth of Phage Stock and Modifications 
2.1 Bacteriophage A511 Propagation 
Phage A511 was obtained from ATCC in a lyophilized form, 
reconstituted using distilled water, and then stored at -20°C. A colony of L. 
monocytogenes was added to 10 mL of BHI broth and incubated, shaking, 
overnight. A small amount of A511 phage was scraped from the top of the 
freezer vial (without thawing) and swished into the culture of L. 
monocytogenes. The phage and bacterial mix were incubated for 24 hours, 
shaking. The tube was then removed, centrifuged at 3000 rpm for 10min, and 
the phage containing supernatant carefully pipetted into freezer tubes and 
stored at -20°C, reserving one tube for the plaque assay. 
 
2.2 Modifications to A511 Growth Method 
After several tests that yielded no plaques, different growth methods 
were attempted. To address contamination issues with early stocks, a filtration 
step with a 0.22 µm filter was added to remove any remaining bacterial cells 
not separated out by centrifugation. A larger volume of original ATCC phage 
stock, either 250 or 500 μL, was added to begin the culture, instead of just a 
scraping of frozen stock. To concentrate bacterial cells before treatment of 
phage, and to prevent further growth, the 25 mL, 24-hour culture of L. 




which the A511 was also added. Before centrifugation or filtering, 0.5 mL 
chloroform was added, mixed, and then allowed to evaporate off in an attempt 
to increase phage concentration by lysing any bacteria that contained phage 
but had not lysed already. After the first few trials, the above changes to the 
original procedure were kept for all subsequent experiments. 
Different incubation times were varied throughout the growth 
procedure. A method of ‘feeding’ the stock was performed in which a 24-hour 
L. monocytogenes liquid culture was treated with A511, allowed to incubate 
overnight, and then ‘fed’ by using a loop to transfer three colonies of L. 
monocytogenes to the tube and incubating for 4 more hours. The bacterial 
culture was incubated for 48 hours before A511 was added from frozen stock, 
and then the phage and bacterial mixture was incubated, monitoring for two 
days for change in apparent cloudiness. In a separate experiment, time trials 
were performed in which a 24-hour liquid culture of L. monocytogenes were 
treated with A511 and then incubated for 24-hours, ‘fed’ with three additional 
colonies of L. monocytogenes, and then three aliquots were taken at one, two, 
and four hours. These aliquots were filtered and chloroformed, and then tested 
for titer.   
The L. monocytogenes stock that had been used was checked under a 
microscope to verify that it appeared to be a bacillus type as it should be, and 
that there were no other contaminants in the stock. In addition, a new vial of L. 
monocytogenes was retrieved from the -80°C freezer and used for subsequent 
experiments. 
New A511 phage was ordered from ATCC and then grown using 




filtration, and chloroform methods described above. This growth trial was 
tested in a plaque assay experiment along with a control of pure, undiluted 
ATCC stock. 
 
3.  Plaque Assay and Modifications  
3.1 Semi-Soft Agar Phage Titer Plaque Assay 
Phage titer procedures were modified from standardized Amrita 
Laboratory online resources for E. coli B. Semi-soft BHI agar was prepared 
ahead of time by adding 0.7% bacto-agar to a standard preparation of BHI 
broth, autoclaving, and then storing at 4°C. All prepared media were used 
within two weeks. A volume of 100 μL of L. monocytogenes overnight culture 
suspension was spread onto each of six BHI agar plates. The semi-soft BHI 
agar was heated on a hot plate until fully melted and then cooled in a water 
bath down to 45°C. Once cooled, 5 mL of semi-solid was added into each of 
five tubes. A serial dilution of A511 phage stock of unknown concentration 
was performed down to 10-9 and 100 μL of each of the 10-5, 10-6, 10-7, 10-8, 10-
9 phage dilution mixtures were mixed into the prepared tubes of 5 mL of semi-
solid agar. Working quickly to prevent solidification of the semi-solid agar, 
the tubes were poured onto the prepared plates of L. monocytogenes. Once the 
agar had solidified, these plates were incubated upside down for 24 hours at 
37°C. 
 
3.2 Modifications to Semi-Soft Agar Plaque Assay 
Due to initial struggles with the texture of the semi-solid agar being an 




were made with 0.5% and 1% agar as well. One attempt was made to use the 
agar by cooling it straight from the autoclave, instead of storing in the fridge 
and re-melting. In later procedures, the 100 μL of bacteria was added straight 
to the mix of semi-solid and phage, instead of plating beforehand. In addition, 
semi-solid was heated with a microwave instead of a hot plate to achieve more 
complete and rapid melting.  
Plaque assays were performed in which plates were left at room 
temperature instead of in the incubator. This slows the growth of bacteria and 
was an attempt to view plaques that may have formed before overgrowth. 
However, no difference in plaque formation was observed and the risk for 
contamination was higher, so plates were placed in the incubator for 
subsequent experiments. 
When no clear plaques were observed even with successful spreading 
of the semi-solid agar, changes in the initial bacterial treatment were made as 
well. The initial bacterial suspension was diluted to 0.1 OD and further serial 
dilutions were made in the suspension until 0.0001 OD. These dilutions were 
mixed into the semi-solid with ratios of phage varying from undiluted to 10-4 
of the original unknown concentration. For example, one experiment with 16 
plates was performed with different combinations of 0.1, 10-2, 10-3, and 10-4 
OD liquid bacterial culture mixed with prepared phage dilutions of 1:0, 1:10, 
1:1,000, and 1:100,000 in media. Trials with different combinations were 
performed, some as low as 10-10 OD dilutions of the bacterial solution. These 
trials were also performed before and after different methods of growing A511 





3.3 Bacterial ‘Lawn’ Plaque Assay 
In later experiments, an alternative method to semi-solid agar was 
adopted to test for PFU/mL. A single colony of L. monocytogenes is retrieved 
from a culture plate and spread thoroughly onto a BHI agar plate, making sure 
to cover the whole area of the plate several times. In triplicate, 10 μL aliquots 
of the A511 phage stock batch to be tested are dropped onto one half of the 
plate. The plates are incubated, right-side up, overnight at 37°C. If overgrowth 
was a concern, plates were checked at 8 and 12-hour time points or incubated 
at room temperature instead. While less accurate, only providing information 
about the minimum number of phage at a particular dilution where plaques 
appear, this method removes the possibility of improperly melted and rapidly 
solidifying semi-solid agar and is much quicker to perform, allowing for more 
efficient testing of the many different methods of A511 growth. 
 
4. Salmonella Growth, Phage Stock, and Biofilm Assay 
4.1 Growth of P22 Phage 
A 50 mL volume of TSB broth was inoculated with a culture of 
Salmonella and incubated for overnight at 37°C. The bacteria were spun down 
and re-suspended in 30 mL of peptone water. An aliquot of 750 μL of P22 
phage was added and the mixture was incubated overnight at 37°C. The stock 
was centrifuged at 3000 x g for 20 minutes and the supernatant was filtered 
with a 0.22 µm filter (VWR, USA). A few 1 mL aliquots were stored at -20°C, 
and the rest was kept for use at 4°C. The PFU/mL of this stock was tested 





4.2 Biofilm Attachment Ability Assay 
A liquid culture of Salmonella was incubated overnight in TSB broth 
and then diluted to 0.1 OD, or about 106 CFU/mL. Prepared 100μL aliquots of 
bacteria at 106, 105, and 104 CFU/mL were added to a 96-well plate in 
triplicate. Each of these was treated with 100μL of undiluted P22 phage stock, 
about 106 PFU/mL. This effectively tested three different multiplicity of 
infection (MOI) values, where 𝑀𝑂𝐼 = 𝑙𝑜𝑔 (
𝑃𝐹𝑈
𝐶𝐹𝑈
), and so MOI’s tested were 0, 
1, and 2. Controls of 100 μL 106 CFU/mL bacteria with 100 μL peptone water, 
and 100 μL TSB broth with 100 μL peptone water were used. After 24 hours 
of incubation, the cell suspensions in each of the wells of the 96-well plate 
were transferred to a new plate, being sure not to disturb the adhered cell 
layer. Absorbance readings at 570 nm for these cell suspensions, along with 
the controls, were obtained. 
 
4.3 Enumeration of attached cells 
The adhered cells from the 96-well plate were rinsed gently with 100 
μL of peptone water to aspirate off loosely adhered cells. They were then 
mixed vigorously with another 100 μL of peptone water and diluted down to 
10-3 and 10-4 of their original concentration with peptone water. Twenty-five 
microliter aliquots of each were spread in triplicate onto TSB agar plates 
divided into thirds. The plates were incubated for 24 hours and then colonies 
were counted within each third. This experiment was repeated three times, 







Prior to beginning phage-bacterial cell interaction test, standard curves 
for Listeria monocytogenes ½a were calculated. This growth curve was used 
to pick the volume of bacterial suspension needed for meeting the required 
CFU of multiplicity of infection (MOI) against bacteriophage. A standard 
curve for L. monocytogenes ½a was successfully developed as shown in 
Figure 4. 
L. monocytogenes Standard Curve  
 
Figure 4: L. monocytogenes Standard Curve. Standard curve showing 
resulting CFU/mL of bacterial solutions of various OD’s (inferred from serial 
dilution). Results are representative of a triplicate experiment. Error bars 
represent standard error of the mean. 
 
As seen by the y-axis, ODs greater than 10-1 and less than 10-8 were 
unable to produce a measurable absorbance reading and resulting colony 






















count. This provided a method of controlling CFU/PFU for biofilm attachment 
ability and enumeration experiments.  
Low L. monocytogenes Concentration Tests 
It was found that the A511 phage was unable to produce plaques when 
applied using a semi-soft agar. To determine whether or not there was low or 
negligible activity of the phage stock, titer experiments were performed using 
high phage concentrations and low bacterial concentrations. A combination of 
10-1 phage concentration and 10-10 bacteria concentration was tested, and there 
were no visible plaques as seen in Figure 5. At these extreme concentration 
values, at which the phage concentration is at its upper bound and the bacterial 
concentration is at its lower bound, there are still no visible plaques seen on 
the agar plate.  
 
Figure 5: Ascertaining Phage Stock Titer. Titer experiment with semi-solid 
1% agar, bacterial concentration of 10-10 OD and A511 phage concentration 
of 10-1 of the unknown stock concentration. No visible plaques at such low 




Irregularity of Semi-Soft Agar  
The first iteration of titer experiments utilized a semi-soft agar in order 
to allow the bacteria and phage to interact with each other. Different 
concentrations of semi-soft agar were utilized to determine the optimal agar 
concentration for spreading. First, a 1% semi-soft media was used which can 
be seen in Figure 6A & B. Following this, a 0.7% semi-soft media was tested 
as well which can be seen in Figure 6C. Both concentrations resulted in 
inconsistencies in spreading as seen by the uneven surfaces produced by the 
agar on the plates.  
 
Figure 6: Variability of Semi-soft Agar. Titer experiments showing 
variability of the agar spreading. Image A used 1% agar semi-soft media 
mixed with bacteria at 10-2 OD and phage at 10-1 of the stock. Image B used 
1% agar semi-soft media mixed with bacteria at 10-3 OD and phage at 10-4 of 
the stock. Image C used 0.7% agar. In each case agar was melted with a 










L. monocytogenes Lawn Plaque Assay Initial Results  
Following the series of semi-soft agar experiments performed, grass 
experiments were utilized in order to determine methods of improving the 
phage stock testing process. The phage stock was directly applied to a grass 
lawn of bacteria. This initially resulted in what was thought to be promising 
results as seen in Figure 7A, but it was soon realized that the plaque-like 
structures on the plate were actually just disturbances in the bacterial layer 
from the initial dropping of phage onto it. Due to the inconclusive results from 
the initial grass experiments, further testing was performed with newly grown 
phage at various phage and bacterial concentrations. After multiple iterations, 
it was determined that there were no plaques visible, even at high phage 
concentrations as seen in Figure 7B. 
 
 
Figure 7: Lawn Plaque Assay. Image A shows a lawn experiment resulting in 
bacterial disturbances, but no plaques. Initially, the results were interpreted to 
be plaques. Image B shows a lawn experiment using a new trial of grown 
A511 at undiluted (100), 10-1, and 10-2 dilutions of the trial stock. However, no 






To further confirm that plaques were not simply obscured by bacterial 
overgrowth, various temperatures for bacterial growth were used to slow the 
growth rate. As seen in Figure 8, a room temperature environment did not 
help improve the presence of plaques, despite the decrease in bacterial growth. 
 
Figure 8: Lawn Plaque Assay at Room Temperature. Lawn experiment 
using Listeria at room temperature to slow bacterial growth rate, in order to 
determine whether plaques were formed but then overgrown. Resulting plate 
is cloudy and unreadable, indicating no plaques.  
 
In order to verify that the stock of L. monocytogenes that was being 
used was not contaminated at some point, the bacterial stock from the freezer 
was Gram-stained and placed under a microscope. Figure 9 shows that the 
morphology of the cells appears to be consistent with the expected 
coccobacilli of L. monocytogenes. This showed that the stock used for 
previous experiments were likely not affected by a contaminated bacterial 
source. Despite this confirmation, future experiments were performed with a 






Figure 9: Gram-stain of L. monocytogenes. Contamination check via 
staining to confirm presence of Listeria at 1000x magnification. Cells appear 
to be coccobacilli and Gram-stain purple, consistent with Listeria 
monocytogenes. 
 
Using newly ordered ATCC A511, several more grass experiments to 
determine titer of phage grown with that new stock were attempted. As seen in 
Figure 10A & B, no plaques appeared to be present despite the newly 







Figure 10: Lawn Plaque Assay Using New ATCC A511. Image A shows a 
lawn experiment using new ATCC stock from a second order. Stock was 
filtered and chloroformed, but no plaques were visible. Image B shows two 
plates, a test and a control. The left shows a lawn experiment using fresh 
phage and bacterial stocks with phage stock concentrations from 100 to 10-4. 
No plaques present. The right shows a control plate with the bacteriophage 
stock plated in absence of bacteria. The lack of growth on this control plate 
shows that our bacteriophage stock was not contaminated with bacteria.  
 
A511 phage straight from the small volume obtained from ATCC was 
plated on a grass experiment. Figure 11 shows that while plaques formed, 
they were only present up to the 10-2 dilution of the original ATCC A511 
stock. This means that the purchased stock had a concentration of about 104 






Figure 11: Lawn Plaque Assay Using Undiluted ATCC A511. Direct 
application of pure, reconstituted ATCC A511 phage stock. Top left quadrant: 
control quadrant. Top right: phage concentration of 10-2. Bottom right: phage 
concentration of 10-1. Bottom left: phage concentration of 100(undiluted pure 
stock).  Very few plaques are present in the 10-2 quadrant, indicating low 
phage titer. 
 
Because prior attempts to grow A511 from this ATCC stock had failed 
to show plaques, a parallel experiment was performed using Salmonella and 
P22 phage so the methods of phage growth could be verified. Figure 12 




the A511 sample failed to show plaques on L. monocytogenes while P22 
showed plaques on Salmonella even at very low dilutions (P22 dilutions of 10-
5 and 100 are shown in Figure 12). This lead to the conclusion that the methods 
and materials currently available to the team were insufficient to successfully 
grow A511 phage, and marked the pivot to Salmonella tests as a control case.  
L. monocytogenes vs. S. enterica serovar Typhimurium:  
 
Figure 12: Parallel Lawn Plaque Assays of A511 and P22. Parallel testing 
of grass experiments using Listeria (left) and Salmonella (right). Same 








Figure 13: Plaque Formation of P22 
Application on S. typhimurium. 
Salmonella grass experiment using a P22 
10-5 phage stock dilution. Presence of 
plaques at this concentration indicate an 






For testing on Salmonella biofilm, the working stock of P22 was 
determined to have a titer of 107 PFU/mL, as shown in Figure 13, a cropped 
and magnified version of Figure 12. This was tested on biofilms in varying 















Prior to beginning phage experimentation, standard curves for both S. 
Typhimurium and L. monocytogenes ½a were calculated. These growth curves 
were necessary for later calculations of multiplicity of infection (MOI). A 
standard curve for L. monocytogenes ½a was successfully developed as shown 
in Figure 4. As seen by the y-axis, ODs greater than 10-1 and less than 10-8 
were unable to produce a measurable absorbance reading and resulting colony 
count. This provided a method of controlling CFU/PFU for biofilm attachment 
ability and enumeration experiments.  
Bacteriophage titer measurement was attempted via semi-soft agar 
plaque assay (3.1) At first, this method seemed to limit total bacterial growth; 
however, because there were no clear plaques on these plates, it was 
inconclusive whether or not this was caused by the phage activity or some 
other issue with the procedure. After further testing, it became clear that 
bacterial overgrowth occurred, so variations in the original method were made 
to reduce starting bacterial concentration in the plaque assay (3.2) 
When bacterial overgrowth occurs, the phage tend to infect cells less 
successfully due to the threshold MOI for lysogeny not being reached 
(Abedon, 2016). To decrease bacterial concentration on these plates, bacterial 
solutions were diluted to lower ODs which correspond to lower concentration 
of bacteria per mL in accordance with the standard curve. This was to ensure 
that the CFU:PFU ratio was more skewed in favor of the phage, and ensure 
that the minimum lysogenic MOI was reached. However, even with varied 
initial plating concentrations, consistent plaque formation was not observed 




difficulties with performance of the semi-soft agar, it was inferred that there 
may have been an issue with semi-soft agar composition or melting method 
(3.1) In many experiments, the semi-soft agar solidified rapidly after melting 
such that it would fail to spread evenly on the plates or appear lumpy after 
spreading. This would prevent an even distribution of bacteria and phage 
across the whole plate, making any resulting plaque count un-observable or 
unreliable (Figure 6 A-C). It was also thought that very viscous agar reduces 
the rate of diffusion of phage across the plate, which inhibits its ability to 
infect the target bacteria. At first, instead of plating bacteria and then pouring 
the phage/semi-soft agar mixture on top, both bacteria and phage were added 
to the semi-soft agar and poured onto a clean plate to attempt a more even 
mixing. When no plaques were observed and agar spreading problems 
persisted, different agar preparation methods were attempted. 
Modifications to the semi-solid agar composition proved unreliable, 
with lower agar percentages failing to solidify properly. Different reheating 
methods such as high temperature microwave melting followed by cooling in 
a hot water bath led to contamination issues from the water bath (3.2). It is 
also possible that initially autoclaving the semi-soft agar led to inconsistencies 
within the mixtures themselves, rendering any re-melting or remixing 
ineffective. Even when these modifications in methods resulted in an even 
spread of agar across the plate and extremely low initial bacterial 
concentrations were plated, plaque formation was not observed. Therefore, a 
new method of a ‘lawn’ plaque assay was adopted, allowing for the 
elimination of semi-soft agar as an experimental variable (3.3). While this 




plated in each experiment, it provides a minimum PFU/mL measurement. If 
plaques are visible at a particular phage dilution, then there must be at least 
one phage within the plated volume, and the PFU/mL can be estimated. 
Result of the ‘grass’ method were initially hopeful, as plates showed 
what appeared to be plaques (Figure 7A & B). However, results were varied 
and unrepeatable. It may have been that when the phage solution was dropped 
onto the plate, the bacterial layer was disturbed, resulting in an observation of 
displaced bacteria rather than lytic activity. After several trials, it was 
concluded that the phage stock used for these trials may simply be too low 
concentration to produce plaques. A set of new trials to increase concentration 
of the phage stock began.  
Initially phage stocks were contaminated, so a filtration step was added 
to the procedure. In an attempt to make bacterial cells more susceptible to 
infection, they were grown first in a normal BHI broth and then concentrated 
into a smaller volume of A511-treated nutrient-less peptone water that would 
essentially “starve” the bacteria and prevent further growth. After these initial 
changes to the growth procedure still failed to produce plaques in a ‘lawn’ 
experiment, methods to concentrate the stock were attempted. Phage stock was 
‘fed’ with cultures of bacteria from a loop and then incubated and filtered 
again. To slow growth of bacteria, some trials were left at room temperature, 
to ensure that bacterial overgrowth was not covering up existing plaques, but 
these trials showed no plaques (Figure 8).  
To further ensure there was no contamination within the L. 
monocytogenes culture, the cells were observed under a microscope and no 




fresh stocks of L. monocytogenes were retrieved from the -80℃ freezer and a 
fresh A511 stock from ATCC was purchased and used in a new phage growth 
trial. Even with these efforts using fresh stocks, no plaques were observed 
(Figure 10A & B).  Returning to the theory that the A511 phage was not 
aggressive enough to observe plaque formation, pure ATCC phage stock was 
used on bacterial cultures (Figure 11). The pure ATCC stock showed a titer of 
102 PFU/mL, which is very low.  This led to the tentative conclusion that the 
purchased pure A511 phage vial as a whole may have had a low titer. The 
ATCC acquired A511 phage was not only of an unknown concentration, but 
several years old. The phage sent to us by ATCC was preserved via 
lyophilization, a process which has been found to decrease the titer of 
Staphylococcus aureus phage ISP as a result of the destabilization of the phage 
components during the freezing process. Immediately after lyophilization, 
phage titer in sucrose solutions decreased by a factor of two and continued to 
decrease by as much as a factor of six after three years of storage. Higher 
concentrations of sucrose lessen the degradation to only a factor of two over 
that three-year time scale (Merabishvili et al., 2013). It is also possible that 
mistakes were made by our team in the initial inoculation of the phage, leading 
to a reduced titer. When treating the bacteria with phage, the overall treatment 
was likely not high enough to kill enough bacteria for phage propagation. This 
led to having a phage solution with a high amount of bacterial growth and a 
low or non-existent phage. These circumstances could in part explain 
difficulties with lack of phage growth and subsequently lack of observing 
phage growth on varying concentrations of L. monocytogenes cultures, even 




As a control for the procedures used with L. monocytogenes against 
A511 phage, Salmonella against P22 phage were tested. Salmonella has 
previously shown susceptibility to P22 phage (Ahn, Kim, Jung, & Biswas, 
2013). As shown in Figure 12, an experiment in which exactly the same 
phage growth, purification, and plaque assay methods were used resulted in 
plaque formation for Salmonella treated with P22, but no plaque formation for 
L. monocytogenes treated with A511. These results are evidence that there 
were issues with our personal phage stock, which limited plaque formation. 
Using the bacterial “lawn” assay, the P22 phage stock titer was found 
to be about 106 PFU/mL (Figure 13). This stock was stored and used for S. 
enterica biofilm experiments. Initial S. enterica biofilm tests showed that 
bacteria initially plated at 0.1 OD resulted in lower adhered bacterial 
concentrations after incubation with phage (0.519, 0.547, and 0.379 OD) than 
those initially plated at 0.01 OD (0.874, 0.705, and 0.954 OD). A similar 
pattern of overgrowth was apparent in the planktonic cell count as well. This 
may be due to an overgrowth of S. enterica at 0.1 OD, leading to a lack of 
nutrients left available over time and causing a higher amount of bacterial 
death at that concentration. It is possible that the P22 phage solution of 106 
PFU/mL was not concentrated enough to overcome S. enterica growth at this 
MOI, though efforts could be made to re-grow this phage stock and 
concentrate it to 1010 PFU/mL, the concentration at which it showed activity 
previously (Ahn, Kim, Jung, & Biswas, 2013). Other studies have shown a 
reduction in Salmonella planktonic cell count of 105 CFU/mL after four hours 
of incubation with phage (Birendra, Kim & Kim, 2013). Due to time 




Furthermore, across nearly all of the experiments, a constant 
temperature of 37°C was used to grow the phage-applied bacteria plates. 
Despite an attempt to incubate the bacteria at room temperature, no other trials 
were conducted under different temperatures. One of the driving factors for 
phage efficacy involves determining the optimal temperature for phage 
receptors to adhere to the bacterial cells. An experiment testing the efficiency 
of two Listeria phages similar to P-100, LP-048 and LP-125, found that 
temperature is an extremely important parameter to control when applying 
phage. The study found that at 37°C, LP-048 exhibited severe decrease in 
adsorption efficacy and plaque formation in response to strains 1/2a, 1/2b, 4a, 
indicating a downregulation of phage receptor rhamnose. Additionally, LP-
048 was shown to produce plaques at 37°C on a mutated strain lacking N-
acetylglucosamine, suggesting that competition between N-acetylglucosamine 
and rhamnose for glycosylation sites occurs during infection (Tokman, Kent, 
Wiedmann, & Denes, 2016). As such, the temperature that we incubated our 
plates at seem to be detrimental to phage infection and multiplication. 
Successful A511 and P100 testing at 6°C and 20°C on ready-to-eat foods 
corroborate the implication that 37°C is not an ideal temperature for growing 
or examining Listeria phage (Guenther, Huwyler, Richard, & Loessner, 2009). 
At higher temperatures, the ability of A511 to infect bacteria begins to 
significantly decline. A study testing Listeria phage A511 on Listeria ivanovii 
3009 discovered that this phage was the most sensitive to environmental 
changes with respect to other commonly used phages such as Salmonella 
phage Felix O1 and E. Coli phage T7. At 4°C, there was no detectable 




that A511 activation was slowed down and had lost 2 log PFU after 21 days. 
At 60°C, the sensitivity of the A511 increased even higher, losing 4 log PFU 
in 5 minutes (Kim, 2007). Therefore, temperature is a key factor that can be 
further varied in future experiments and is likely a large contributor to the lack 
of activity witnessed across the data collected.  
Current Research 
The use of bacteriophage against bacterial biofilms is a promising 
research area. During the three years of research for this project, thousands of 
research articles were published describing the positive aspects of using 
bacteriophage as disinfectants. Despite our work being inconclusive, other 
scientists have performed similar experiments and reported significant 
success. One group tested two Salmonella phages against S. enterica serovar 
Typhimurium and S. enterica serovar Enteritidis biofilms on rubber, stainless 
steel, and lettuce (Sadekuzzaman, Mizan, Yang, Kim & Ha, 2018). They 
carried out a method similar to the team’s, including finding ways to 
concentrate phage stocks. On stainless steel, the phage treatment reduced 
biofilm cells by approximately 103 CFU/cm2. On the rubber surface, the phage 
treatment reduced biofilm cells by more than 102 CFU/cm2. Trials on lettuce 
were tested at varying temperatures, however, the bacterial load was 
significantly reduced for each temperature. To assess phage treatment in a 
controlled smooth surface, an MBEC assay was performed and showed that 
the phage treatment reduced biofilm cells up to 103.6 CFU/peg 
(Sadekuzzaman, Yang, Mizan, Kim & Ha, 2018). 
A secondary reason bacteriophages are thought to be effective against 




infect persister cells. Persister cells are inactive bacterial cells embedded in 
biofilms with relatively no metabolic activity, and regain normal function if 
damage occurs to the biofilm. These persister cells are a major facet of biofilm 
tenacity. Bacteriophages have the ability to infect these dormant cells, and 
when the cell activates, the bacteriophage lyses the cell. A study by Harper et 
al. in 2014 confirmed this phenomenon in Pseudomonas aeruginosa biofilms, 
noting the ability of phages to kill biofilms in situations where antibiotics 
could not. A study found that 97% S. enteritidis biofilm reduction after only 4 
hours of contact with their phage stock, with 100% of phage adsorption 
achieved after only 15 minutes (Tiwari, Kim, Kim). 
Other studies corroborate phage killing of persister cells immediately 
upon metabolic activation. The same ability was recorded using the hipA7 
strain and the λ-phage, showing 90% reduction of the colonies under 
microscope. Furthermore, the lytic activation of phages was shown to directly 
follow the resumption of persister cell growth functions. The researchers make 
the point that this is another adaptive ability of phage, as phage lysis of 
nutrient-deprived cells has also been studied. T4 phages can enter stasis if the 
host bacteria is starved of resources, reactivating only when nutrients are 
acquired in order to optimize phage production. The flexibility and 
adaptability of phages is the foundation of their effectiveness against biofilms 
(Pearl, Gabay, Kishony, Oppenheim & Balaban, 2008). 
There are many other directions that phage therapy has taken. Some 
institutions have heavily researched phage endolysins - lytic enzymes used to 
lyse the host cell by enzymatically degrading the peptidoglycan in the 




process of infecting bacteria with bacteriophage and moves directly to lysing 
the host cell. Some endolysins, such as PlyGRCS, have shown to be effective 
in directly lysing cells in biofilms (Linden et al., 2015.) However, it is most 
effective on Gram-positive bacteria, since the outer membrane of Gram-
negative bacteria interfere with the activities of endolysins (Love, Bhandari, 
Dobson, & Billington, 2018). Furthermore, the endolytic phage derivatives 
were also shown to lyse bacteria in biofilms more quickly than topical phage 
application. One group of researchers measured the efficacy of a phage 
cocktail composed of bacteriophage K and 6 modified derivatives on 
Staphylococcus aureus found that the cocktail was able to inhibit biofilm 
growth after 48 hours, when applied immediately. Treatment with the same 
cocktail after 72 hours of biofilm growth, however, yielded an even larger 
drop in biomass, showing that a later application was more effective. A 
different group of researchers then used the phage lysin CHAPk on the same 
Staphylococcus bacteria, reporting that it only took 4 hours to eliminate the 
biofilm (Endersen et al., 2014). This is evidence that even more effective anti-
biofilm products can be derived from phages, such as endolysins, though more 
research is needed directly comparing whole bacteriophages and endolysins.  
All of these methods have applications in food safety, and even clinical 
care due to the specificity of both bacteriophage and their endolysins. The 
large body of work between these directions also emphasizes the relevance 








Due to the limited timespan and extensive scope of the project, any 
obstacles in research severely interfered with data collection. The main factors 
that hindered progress were time sensitivity of experiments, delays in 
receiving materials, and significant issues with phage growth. 
Over a year of research was spent testing and altering experiments with 
Listeria phage A511 - growing and concentrating the phage stock, attempting 
to optimize the titer experiment, and troubleshooting bacteriophage infection 
of Listeria biofilms. The team invested a significant amount of time and 
money, and with the prior restrictions on phage access it was difficult to pivot 
to a different phage in a timely fashion. Investigation of the original 
lyophilized Listeria phage A511 received from ATCC revealed it to be more 
than 12 years old which may have reduced its activity below effective levels.  
 An additional several months to a year would make a significant 
impact on the amount of data collected. When the team decided to switch from 
testing Listeria to Salmonella, it was the fall semester of the final year. As 
mentioned previously, the Salmonella phage P22 was shown to be effective on 
Salmonella, thus providing the team with an alternative route which would 
allow for testing an active, concentrated phage stock as a control for the 
procedures used on Listeria and a proof-of-concept. Unfortunately, switching 
at this point in the timeline did not leave sufficient time for all of the initial 
project goals to be completed.  
 There are multiple different tests that the team planned on conducting. 
The first would be to alter the temperature at which the phage stock was 




processing industry, which keeps its work areas typically at near-freezing. 
Next would be to test the effectiveness of bacteriophage cocktails in 
conjunction with non-phage substances, like peracetic acid, to boost total 
bacterial eradication. Another interesting extension of the project that the team 
planned was to combine bacterial species in a biofilm, such as Salmonella and 
Listeria, and observe the effects of bacteriophage on this consortium. It is 
possible that multiple types of bacteria residing in the biofilm could afford 
more protection, reducing the effectiveness of a bacteriophage cocktail. 
Further research can also be done on the most effective application method of 
phages. There is evidence that aerosolized sprays can be effective, but there a 
wide range of options in product design to explore.  While the team was not 
able to demonstrate efficacy of Listeria phage A511 against L. monocytogenes 
1/2a within this time frame, the team was able to explore and report a host of 
different methods for phage growth, as well as reproduce promising data for 
P22 phage against Salmonella enterica serovar Typhimurium. The wealth of 
recent research and continued expansion of commercial phage disinfectant 






Appendix: Glossary (denoted by “*”) 
Aliquot: A portion of a given substance. 
Brain-heart infusion broth: A nutrient growth medium used for 
culturing bacteria which combines dextrose broth and brain tissue. 
Burst size: Average number of phage particles liberated when an 
infected bacterium is lysed.  
Extracellular polymeric substance (EPS): An extracellular matrix 
composed of a conglomeration of biopolymers that assist in biofilm 
formation. 
Inoculate: To introduce one thing to another, generally cells to a 
medium or a treatment to cells, and generally a specific measurement.  
Peptidoglycan: The structure that makes up the cytoplasmic 
membrane of nearly every eubacteria. 
Persister Cell: A form of effectively dormant bacterial cell that grows 
within a biofilm and resists uptake of antibiotics but can give rise to 
whole new colonies of bacteria. 
Phage cocktail: The mixture of selected phages as well as any other 
supporting agents in a solution.  
Rescue: Restoration of the effectiveness of an antibacterial agent that 
bacteria have become immune to by addition of another agent.  




Transfection: The purposeful introduction of nucleic acid material 
into cells. 
Transduction: Bacteriophage infection to incorporate foreign DNA 
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